Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium

Hye Y. Nam; Arlo McGinn; Pyung Hwan Kim; Sung W. Kim; David A. Bull

doi:10.1016/j.biomaterials.2010.07.025

Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium

Hye Y. Nam, Arlo McGinn, Pyung Hwan Kim, Sung W. Kim, David A. Bull

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Abstract

A cardiomyocyte-targeted Fas siRNA delivery system was developed using primary cardiomyocyte (PCM) specific peptide-modified polymers with high transfection efficiency and low cytotoxicity. Primary cardiomyocyte (PCM) specific peptide, selected by phage display, was conjugated to bioreducible poly(cystamine bisacrylamide-diaminohexane, CBA-DAH) (PCD). The specificity of the PCM-modified polymer to cardiomyocytes was confirmed by competition study with free PCM ligand and by delivery to non-cardiomyocyte NIH 3T3 fibroblasts. The cellular binding and uptake of the PCM-polymer/pDNA polyplex was inhibited by addition of free PCM peptide. The impact of PCM conjugation on cellular uptake and transfection efficiency was greater in H9C2 rat cardiomyocytes than in NIH 3T3 cells. Fas siRNA/PCM-polymer polyplexes exhibited significant Fas gene silencing in rat cardiomyocytes under hypoxic conditions, leading to inhibition of cardiomyocyte apoptosis. These findings demonstrate the utility of the addition of a primary cardiomyocyte (PCM) specific peptide modification to a bioreducible polymer for targeted delivery of Fas siRNA to inhibit cardiomyocyte apoptosis.

Original language	English (US)
Pages (from-to)	8081-8087
Number of pages	7
Journal	Biomaterials
Volume	31
Issue number	31
DOIs	https://doi.org/10.1016/j.biomaterials.2010.07.025
State	Published - Nov 2010
Externally published	Yes

Keywords

Bioreducible polymer
Cardiomyocyte
Fas
PCM
SiRNA

ASJC Scopus subject areas

Mechanics of Materials
Ceramics and Composites
Bioengineering
Biophysics
Biomaterials

Access to Document

10.1016/j.biomaterials.2010.07.025

Cite this

@article{706c75c5bfe1481ab3b1ca74405f2f3d,

title = "Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium",

abstract = "A cardiomyocyte-targeted Fas siRNA delivery system was developed using primary cardiomyocyte (PCM) specific peptide-modified polymers with high transfection efficiency and low cytotoxicity. Primary cardiomyocyte (PCM) specific peptide, selected by phage display, was conjugated to bioreducible poly(cystamine bisacrylamide-diaminohexane, CBA-DAH) (PCD). The specificity of the PCM-modified polymer to cardiomyocytes was confirmed by competition study with free PCM ligand and by delivery to non-cardiomyocyte NIH 3T3 fibroblasts. The cellular binding and uptake of the PCM-polymer/pDNA polyplex was inhibited by addition of free PCM peptide. The impact of PCM conjugation on cellular uptake and transfection efficiency was greater in H9C2 rat cardiomyocytes than in NIH 3T3 cells. Fas siRNA/PCM-polymer polyplexes exhibited significant Fas gene silencing in rat cardiomyocytes under hypoxic conditions, leading to inhibition of cardiomyocyte apoptosis. These findings demonstrate the utility of the addition of a primary cardiomyocyte (PCM) specific peptide modification to a bioreducible polymer for targeted delivery of Fas siRNA to inhibit cardiomyocyte apoptosis.",

keywords = "Bioreducible polymer, Cardiomyocyte, Fas, PCM, SiRNA",

author = "Nam, {Hye Y.} and Arlo McGinn and Kim, {Pyung Hwan} and Kim, {Sung W.} and Bull, {David A.}",

note = "Funding Information: This work was financially supported by NIH grants HL 065447 (SWK) and HL071541 (DAB) . ",

year = "2010",

month = nov,

doi = "10.1016/j.biomaterials.2010.07.025",

language = "English (US)",

volume = "31",

pages = "8081--8087",

journal = "Biomaterials",

issn = "0142-9612",

publisher = "Elsevier BV",

number = "31",

}

TY - JOUR

T1 - Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium

AU - Nam, Hye Y.

AU - McGinn, Arlo

AU - Kim, Pyung Hwan

AU - Kim, Sung W.

AU - Bull, David A.

N1 - Funding Information: This work was financially supported by NIH grants HL 065447 (SWK) and HL071541 (DAB) .

PY - 2010/11

Y1 - 2010/11

N2 - A cardiomyocyte-targeted Fas siRNA delivery system was developed using primary cardiomyocyte (PCM) specific peptide-modified polymers with high transfection efficiency and low cytotoxicity. Primary cardiomyocyte (PCM) specific peptide, selected by phage display, was conjugated to bioreducible poly(cystamine bisacrylamide-diaminohexane, CBA-DAH) (PCD). The specificity of the PCM-modified polymer to cardiomyocytes was confirmed by competition study with free PCM ligand and by delivery to non-cardiomyocyte NIH 3T3 fibroblasts. The cellular binding and uptake of the PCM-polymer/pDNA polyplex was inhibited by addition of free PCM peptide. The impact of PCM conjugation on cellular uptake and transfection efficiency was greater in H9C2 rat cardiomyocytes than in NIH 3T3 cells. Fas siRNA/PCM-polymer polyplexes exhibited significant Fas gene silencing in rat cardiomyocytes under hypoxic conditions, leading to inhibition of cardiomyocyte apoptosis. These findings demonstrate the utility of the addition of a primary cardiomyocyte (PCM) specific peptide modification to a bioreducible polymer for targeted delivery of Fas siRNA to inhibit cardiomyocyte apoptosis.

AB - A cardiomyocyte-targeted Fas siRNA delivery system was developed using primary cardiomyocyte (PCM) specific peptide-modified polymers with high transfection efficiency and low cytotoxicity. Primary cardiomyocyte (PCM) specific peptide, selected by phage display, was conjugated to bioreducible poly(cystamine bisacrylamide-diaminohexane, CBA-DAH) (PCD). The specificity of the PCM-modified polymer to cardiomyocytes was confirmed by competition study with free PCM ligand and by delivery to non-cardiomyocyte NIH 3T3 fibroblasts. The cellular binding and uptake of the PCM-polymer/pDNA polyplex was inhibited by addition of free PCM peptide. The impact of PCM conjugation on cellular uptake and transfection efficiency was greater in H9C2 rat cardiomyocytes than in NIH 3T3 cells. Fas siRNA/PCM-polymer polyplexes exhibited significant Fas gene silencing in rat cardiomyocytes under hypoxic conditions, leading to inhibition of cardiomyocyte apoptosis. These findings demonstrate the utility of the addition of a primary cardiomyocyte (PCM) specific peptide modification to a bioreducible polymer for targeted delivery of Fas siRNA to inhibit cardiomyocyte apoptosis.

KW - Bioreducible polymer

KW - Cardiomyocyte

KW - Fas

KW - PCM

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=77956009639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956009639&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2010.07.025

DO - 10.1016/j.biomaterials.2010.07.025

M3 - Article

C2 - 20674007

AN - SCOPUS:77956009639

SN - 0142-9612

VL - 31

SP - 8081

EP - 8087

JO - Biomaterials

JF - Biomaterials

IS - 31

ER -

Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this